Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
The AstraZeneca vaccine has seen its fair share of controversy this year. Locally, the AstraZeneca batch destined to vaccine health workers was deemed as ineffective and sold off, with government selecting to obtain the more effective Johnson and Johnson vaccine. Recently, however, concerns across Europe over the shot causing blood clots saw numerous countries suspending the rollout. After a prompt investigation, European health officials declared the vaccine safe to use. In the UK, the vaccine has been reserved for those over 30 years, with The Wall Street Journal reporting that ‘the European Union’s health agency said it had found possible links between the AstraZeneca vaccine and rare blood clots but that the shot’s benefits continue to outweigh the potential risks’. – Jarryd Neves
Thursday, 08 Apr 2021 07:19 AM MYT
Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
AMSTERDAM, April 8 European countries should make their own decisions about how to handle the risk of rare blood clots from AstraZeneca’s Covid-19 vaccine, based on prevailing infection rates and the availability of alternative vaccines, the EU drugs regulator said yesterday.
Vaccine panel confirms choice to delay doses up to four months in Canada newsoptimist.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsoptimist.ca Daily Mail and Mail on Sunday newspapers.